Michael Kelly
Experienced in Cardiofaciocutaneous Syndrome

Dr. Michael Kelly

Pediatrics
Cleveland Clinic
Cleveland Clinic Children's Outpatient Center
8950 Euclid Avenue, 
Cleveland, OH 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Cardiofaciocutaneous Syndrome
Cleveland Clinic
Cleveland Clinic Children's Outpatient Center
8950 Euclid Avenue, 
Cleveland, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Kelly is a Pediatrics provider in Cleveland, Ohio. Dr. Kelly is rated as an Experienced provider by MediFind in the treatment of Cardiofaciocutaneous Syndrome. His top areas of expertise are Hereditary Spherocytosis, Congenital Hemolytic Anemia, Hemolytic Crisis, and Hemolytic Anemia.

His clinical research consists of participating in 16 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency
St. Louis Childrens Hospital Washington Univ School of Med
Specialties
Pediatrics
Licenses
Pediatric Hematology-Oncology in OH
Board Certifications
American Board Of Pediatrics, 2002
Fellowships
St. Louis Children's Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AultCare
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
CommuniCare Advantage
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Primetime Health Plan
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE PART D
Provider Partners Health Plan
  • MEDICARE SNP
SummaCare
  • HMO
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Univera Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Cleveland Clinic Children's Outpatient Center
8950 Euclid Avenue, Cleveland, OH 44106
Call: 216-444-8950
Other Locations
Hillcrest Medical Office Building II
6801 Mayfield Road, Mayfield Hts, OH 44124
Call: 440-312-4500

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

16 Clinical Trials

Umbrella Long-Term Follow-Up Protocol
Umbrella Long-Term Follow-Up Protocol
Enrollment Status: Recruiting
Publish Date: July 23, 2025
Intervention Type: Procedure, Other
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Phase 2 Trial of Response-Based Radiation Therapy for Patients With Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Enrollment Status: Completed
Publish Date: November 20, 2025
Intervention Type: Drug, Radiation
Study Phase: Phase 2
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Enrollment Status: Active_not_recruiting
Publish Date: October 27, 2025
Intervention Type: Drug, Radiation, Biological, Other
Study Drugs: Carboplatin, Cisplatin, Cyclophosphamide, Etoposide, Vincristine
Study Phase: Phase 3
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 18, 2025
Intervention Type: Other, Procedure
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Enrollment Status: Active_not_recruiting
Publish Date: April 01, 2025
Intervention Type: Other, Drug
Study Drugs: Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Methotrexate, Pegaspargase, Thioguanine, Vincristine Sulfate
Study Phase: Phase 3
Renal Tumors Classification, Biology, and Banking Study
Renal Tumors Classification, Biology, and Banking Study
Enrollment Status: Active_not_recruiting
Publish Date: March 25, 2025
Intervention Type: Other
A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFI) Following Allogeneic Hematopoietic Cell Transplantation (HCT)
A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFI) Following Allogeneic Hematopoietic Cell Transplantation (HCT)
Enrollment Status: Completed
Publish Date: October 16, 2024
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 1 Study of AZD1775 (MK-1775) Concurrent With Local Radiation Therapy for the Treatment of Newly Diagnosed Children With Diffuse Intrinsic Pontine Gliomas
A Phase 1 Study of AZD1775 (MK-1775) Concurrent With Local Radiation Therapy for the Treatment of Newly Diagnosed Children With Diffuse Intrinsic Pontine Gliomas
Enrollment Status: Completed
Publish Date: January 31, 2024
Intervention Type: Drug, Other, Radiation
Study Drug: Adavosertib
Study Phase: Phase 1
Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Enrollment Status: Completed
Publish Date: October 03, 2023
Intervention Type: Other
A Phase 1/2 Study of AZD1775 (MK-1775) in Combination With Oral Irinotecan in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors
A Phase 1/2 Study of AZD1775 (MK-1775) in Combination With Oral Irinotecan in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors
Enrollment Status: Completed
Publish Date: September 26, 2023
Intervention Type: Drug
Study Drugs: Adavosertib, Irinotecan Hydrochloride
Study Phase: Phase 1/Phase 2
A Phase II Randomized Trial of Irinotecan/Temozolomide With Temsirolimus (NSC# 683864) or Chimeric 14.18 Antibody (Ch14.18) (NSC# 764038) in Children With Refractory, Relapsed or Progressive Neuroblastoma
A Phase II Randomized Trial of Irinotecan/Temozolomide With Temsirolimus (NSC# 683864) or Chimeric 14.18 Antibody (Ch14.18) (NSC# 764038) in Children With Refractory, Relapsed or Progressive Neuroblastoma
Enrollment Status: Completed
Publish Date: October 24, 2022
Intervention Type: Drug, Biological, Other
Study Drugs: Dinutuximab, Irinotecan Hydrochloride, Sargramostim, Temozolomide, Temsirolimus
Study Phase: Phase 2
A Randomized Open-Label Trial of Caspofungin Versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
A Randomized Open-Label Trial of Caspofungin Versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 1/2 Study of BMN 673, an Oral Poly(ADP-Ribose) Polymerase Inhibitor, Plus Temozolomide in Children With Refractory or Recurrent Malignancies
A Phase 1/2 Study of BMN 673, an Oral Poly(ADP-Ribose) Polymerase Inhibitor, Plus Temozolomide in Children With Refractory or Recurrent Malignancies
Enrollment Status: Completed
Publish Date: March 26, 2021
Intervention Type: Other, Drug
Study Phase: Phase 1/Phase 2
Photodynamic Therapy (PDT) for Poor Prognosis Recurrent/Refractory Malignant Brain Tumors - A Phase I Study
Photodynamic Therapy (PDT) for Poor Prognosis Recurrent/Refractory Malignant Brain Tumors - A Phase I Study
Enrollment Status: Completed
Publish Date: February 25, 2019
Intervention Type: Drug
Study Phase: Phase 1
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors
Enrollment Status: Completed
Publish Date: July 19, 2018
Intervention Type: Other
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens
Enrollment Status: Completed
Publish Date: July 16, 2018
Intervention Type: Other
View 15 Less Clinical Trials
Similar Doctors
Akash Patel
Advanced in Cardiofaciocutaneous Syndrome
Dr. Akash Patel
Pediatrics
Advanced in Cardiofaciocutaneous Syndrome
Dr. Akash Patel
Pediatrics

Cleveland Clinic Children's Outpatient Center

8950 Euclid Avenue, 
Cleveland, OH 
 (24.5 miles away)
216-444-8950
Experience:
26+ years
Languages Spoken:
English
See accepted insurances

Akash Patel is a Pediatrics provider in Cleveland, Ohio. Dr. Patel has been practicing medicine for over 26 years and is rated as an Advanced provider by MediFind in the treatment of Cardiofaciocutaneous Syndrome. His top areas of expertise are Tetralogy of Fallot, Hypoplastic Left Heart Syndrome (HLHS), Mitral Atresia, and Wolff-Parkinson-White Syndrome.

Experienced in Cardiofaciocutaneous Syndrome
Dr. Aditi Yadav
Medical Genetics | Pediatrics
Experienced in Cardiofaciocutaneous Syndrome
Dr. Aditi Yadav
Medical Genetics | Pediatrics

Cleveland Clinic

9500 Euclid Ave, 
Cleveland, OH 
 (24.4 miles away)
216-444-2200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Aditi Yadav is a Medical Genetics specialist and a Pediatrics provider in Cleveland, Ohio. Dr. Yadav is rated as an Advanced provider by MediFind in the treatment of Cardiofaciocutaneous Syndrome. Her top areas of expertise are Ulnar-Mammary Syndrome, Increased Head Circumference, Chromosome 13q Deletion, and Autism Spectrum Disorder. Dr. Yadav is currently accepting new patients.

Experienced in Cardiofaciocutaneous Syndrome
Dr. Ali S. Khalili
Pediatric Gastroenterology | Gastroenterology | Pediatrics
Experienced in Cardiofaciocutaneous Syndrome
Dr. Ali S. Khalili
Pediatric Gastroenterology | Gastroenterology | Pediatrics

University Hospitals Medical Group Inc

11100 Euclid Ave, 
Cleveland, OH 
 (24.5 miles away)
216-844-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ali Khalili is a Pediatric Gastroenterologist and a Gastroenterologist in Cleveland, Ohio. Dr. Khalili is rated as an Advanced provider by MediFind in the treatment of Cardiofaciocutaneous Syndrome. His top areas of expertise are Eosinophilic Esophagitis, Delayed Growth, Esophagitis, and Celiac Disease. Dr. Khalili is currently accepting new patients.

VIEW MORE CARDIOFACIOCUTANEOUS SYNDROME DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kelly's expertise for a condition
ConditionClose
      • Advanced
      • Congenital Hemolytic Anemia
        Dr. Kelly is
        Advanced
        . Learn about Congenital Hemolytic Anemia.
        See more Congenital Hemolytic Anemia experts
      • Hemolytic Anemia
        Dr. Kelly is
        Advanced
        . Learn about Hemolytic Anemia.
        See more Hemolytic Anemia experts
      • Hemolytic Crisis
        Dr. Kelly is
        Advanced
        . Learn about Hemolytic Crisis.
        See more Hemolytic Crisis experts
      • Hereditary Spherocytosis
        Dr. Kelly is
        Advanced
        . Learn about Hereditary Spherocytosis.
        See more Hereditary Spherocytosis experts
      • Thalassemia
        Dr. Kelly is
        Advanced
        . Learn about Thalassemia.
        See more Thalassemia experts
      • Experienced
      • Acute Lymphoblastic Leukemia (ALL)
        Dr. Kelly is
        Experienced
        . Learn about Acute Lymphoblastic Leukemia (ALL).
        See more Acute Lymphoblastic Leukemia (ALL) experts
      • Adult Immune Thrombocytopenia
        Dr. Kelly is
        Experienced
        . Learn about Adult Immune Thrombocytopenia.
        See more Adult Immune Thrombocytopenia experts
      • Agranulocytosis
        Dr. Kelly is
        Experienced
        . Learn about Agranulocytosis.
        See more Agranulocytosis experts
      • Alpha Thalassemia
        Dr. Kelly is
        Experienced
        . Learn about Alpha Thalassemia.
        See more Alpha Thalassemia experts
      • Alpha Thalassemia X-Linked Intellectual Disability Syndrome
        Dr. Kelly is
        Experienced
        . Learn about Alpha Thalassemia X-Linked Intellectual Disability Syndrome.
        See more Alpha Thalassemia X-Linked Intellectual Disability Syndrome experts
      • Anemia
        Dr. Kelly is
        Experienced
        . Learn about Anemia.
        See more Anemia experts
      View All 26 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.